ACM
AIGH Capital Management’s scPharmaceuticals SCPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.7M | Sell |
3,867,523
-228,844
| -6% | -$872K | 6.63% | 3 |
|
2025
Q1 | $10.8M | Sell |
4,096,367
-78,000
| -2% | -$205K | 4.46% | 5 |
|
2024
Q4 | $14.8M | Buy |
4,174,367
+50,000
| +1% | +$177K | 4.62% | 6 |
|
2024
Q3 | $18.8M | Buy |
4,124,367
+620,002
| +18% | +$2.83M | 5.3% | 2 |
|
2024
Q2 | $15.2M | Buy |
3,504,365
+115,206
| +3% | +$501K | 4.75% | 4 |
|
2024
Q1 | $17M | Buy |
3,389,159
+282,364
| +9% | +$1.42M | 5.11% | 1 |
|
2023
Q4 | $19.5M | Buy |
3,106,795
+899,786
| +41% | +$5.64M | 7.71% | 2 |
|
2023
Q3 | $15.7M | Buy |
2,207,009
+155,204
| +8% | +$1.11M | 7.44% | 2 |
|
2023
Q2 | $20.9M | Sell |
2,051,805
-23,992
| -1% | -$244K | 8.53% | 2 |
|
2023
Q1 | $18.8M | Sell |
2,075,797
-474,437
| -19% | -$4.3M | 6.94% | 2 |
|
2022
Q4 | $18.3M | Buy |
2,550,234
+1,793,171
| +237% | +$12.9M | 6.02% | 5 |
|
2022
Q3 | $4.94M | Sell |
757,063
-589,661
| -44% | -$3.84M | 1.53% | 17 |
|
2022
Q2 | $6.49M | Sell |
1,346,724
-50,000
| -4% | -$241K | 1.71% | 15 |
|
2022
Q1 | $7.93M | Buy |
1,396,724
+23,600
| +2% | +$134K | 1.95% | 14 |
|
2021
Q4 | $6.89M | Buy |
1,373,124
+139,003
| +11% | +$698K | 2.1% | 14 |
|
2021
Q3 | $8.21M | Buy |
1,234,121
+591,967
| +92% | +$3.94M | 1.73% | 16 |
|
2021
Q2 | $3.92M | Sell |
642,154
-212,988
| -25% | -$1.3M | 0.71% | 27 |
|
2021
Q1 | $5.69M | Buy |
855,142
+217,820
| +34% | +$1.45M | 1.2% | 19 |
|
2020
Q4 | $3.37M | Buy |
+637,322
| New | +$3.37M | 1.37% | 21 |
|